Literature DB >> 31493469

MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.

Sanna Khan1, Humaira Ayub1, Taous Khan2, Fazli Wahid3.   

Abstract

Micro-ribonucleic acids (miRNAs) are important class of short regulatory RNA molecules involved in regulation of several essential biological processes. In addition to Dicer and Drosha, over the past few years several other gene products are discovered that regulates miRNA biogenesis pathways. Similarly, various models of molecular mechanisms underlying miRNA mediated gene silencing have been uncovered through which miRNA contribute in diverse physiological and pathological processes. Dysregulated miRNA expression has been reported in many cancers manifesting tumor suppressive or oncogenic role. In this review, critical overview of recent findings in miRNA biogenesis, silencing mechanisms and specifically the role of miRNA in breast, ovarian and prostate cancer will be described. Recent advancements in miRNA research summarized in this review will enhance the molecular understanding of miRNA biogenesis and mechanism of action. Also, role of miRNAs in pathogenesis of breast, ovarian and prostate cancer will provide the insights for the use of miRNAs as biomarker or therapeutic agents for the cancers.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Involvement of regulatory proteins; mRNA silencing; miRNAs association with cancer; microRNA biogenesis

Mesh:

Substances:

Year:  2019        PMID: 31493469     DOI: 10.1016/j.biochi.2019.09.001

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  28 in total

1.  microRNA-26b inhibits growth and cellular invasion of ovarian cancer cells by targeting estrogen receptor α.

Authors:  Guna He; Xiaomei Liu; Lingyu Liu
Journal:  3 Biotech       Date:  2022-07-12       Impact factor: 2.893

2.  [MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].

Authors:  Z Huang; H Shen; H Deng; L Sun; B Qü
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 3.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

4.  CircRNA Hsa_circ_0001017 Inhibited Gastric Cancer Progression via Acting as a Sponge of miR-197.

Authors:  Hui Li; ChangPing Shan; JunYe Wang; ChengJiu Hu
Journal:  Dig Dis Sci       Date:  2020-08-01       Impact factor: 3.199

5.  Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients.

Authors:  Binghui Liu; Juhua Pan; Chenglin Fu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

6.  Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.

Authors:  Junjun Shu; Ling Xiao; Sanhua Yan; Boqun Fan; Xia Zou; Jun Yang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  Small Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Arun Kumar Verma; Eshan Khan; Subodh Kumar Mishra; Amit Kumar
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

Review 8.  Circulating exosomal miRNAs and cancer early diagnosis.

Authors:  L Zhu; L Zhao; Q Wang; S Zhong; X Guo; Y Zhu; J Bao; K Xu; S Liu
Journal:  Clin Transl Oncol       Date:  2021-09-15       Impact factor: 3.405

Review 9.  Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story.

Authors:  Ugo Ala
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

Review 10.  The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness.

Authors:  Kou-Juey Wu
Journal:  Biomed J       Date:  2020-04-13       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.